Menu Close

Category: Daily News

9th Circuit Defines MMI Status in Longshore Case

In 1987, Robert Carrion sustained a severe knee injury while working as a chassis mechanic for Matson Terminals, Inc.. Although Carrion returned to his physically demanding job and worked for the next fifteen years, his knee continued to deteriorate. He took early retirement in 2002, when his pain became so great that he could walk only with difficulty. After Carrion’s former employer ceased paying for treatment, he filed for disability under the Longshore and Harbor Workers’ Compensation Act.

By the time he filed his claims in 2008, Carrion had endured decades of persistent pain without any actual or expected improvement. His doctors unanimously concluded that he eventually would require total knee replacement surgery. Even though no surgery was on the horizon, his employer classified the injury as a temporary disability.

The Administrative Law Judge determined that “[a]t first blush, it seems [Carrion’s] injury is permanent,” and acknowledging that Carrion’s “condition has lasted for a long period of time,” the ALJ nevertheless concluded that Carrion’s disability was temporary. The ALJ reasoned that Carrion was contemplating knee replacement surgery, which his doctors agreed would likely alleviate his symptoms, and thus “medical improvement through the knee replacement was available” once “his pain became too much.” The ALJ noted, however, that if Carrion decided against surgery and opted to “live with the knee pain indefinitely, he would be found permanently disabled.”

The employer appealed the ALJ’s timeliness determination to the Benefits Review Board (“BRB” or “the Board”), and Carrion cross-appealed the ALJ’s finding that his disability was temporary. The BRB affirmed the ALJ on both issues. The 9th Circuit Court of Appeal granted the cross-appeal and found Carrion to be permanently disabled in the published case of SSA Terminals and Homeport Insurance Co. v Carrion.

One of the questions addressed by the 9th Circuit Court of Appeals is whether, after such a protracted period of disability, the prospect of a hypothetical future surgery and its anticipated benefits can transform an otherwise permanent disability into a temporary one for purposes of the Longshore Act.

The Longshore Act creates “two independent areas of analysis,” one assessing the nature, or duration, (temporary versus permanent) and the other the degree of the disability (partial versus total).Four separate disability categories stem from this framework: permanent total disability; temporary total disability; permanent partial disability; and temporary partial disability.Two of these qualifiers, permanent and temporary, “go to the nature of the disability.” The Longshore Act does not define “temporary” or “permanent,” although the classification issue arises on a continuing basis.

Courts have held that “[a] disability is temporary ‘so long as there [is] a possibility or likelihood of improvement through normal and natural healing.” Castro, 401 F.3d at 968 (quoting Stevens, 909 F.2d at 1259) (second alteration in original). A disability may become permanent if (1) a claimant reaches “maximum medical improvement” – the point at which “the injury has healed to the full extent possible” and normal and natural healing is no longer likely, Stevens, 909 F.2d at 1257 (citing Watson v. Gulf Stevedore Corp., 400 F.2d 649, 654 (5th Cir. 1968)); or (2) the condition has “continued for a lengthy period, and it appears to be of lasting or indefinite duration, as distinguished from one in which recovery merely awaits a normal healing period.” Watson, 400 F.2d at 654. The Watson test clarifies that “permanent” is not tantamount to “eternal” or “everlasting” and “does not foreclose the possibility that [the] condition may change.”

The 9th Circuit concluded that evaluating an individual’s condition based on the presumed effect of a theoretical future treatment makes scant sense – particularly in light of the “vicissitudes of the individual’s responsiveness to medical treatment.”

DWC Announces New IMR Search Tool

The Division of Workers’ Compensation (DWC) has added an easy-to-use search tool to help the public find Independent Medical Review (IMR) determinations quickly and efficiently. The DWC IMR search tool is available on the DWC website.

Over 300,000 IMR cases have been decided since the medical dispute resolution process was implemented on January 1, 2013. Following a determination by a physician reviewer, information for each case is posted to the DWC website. The public can use the new tool to search for decisions by case number, date of injury, specialty of reviewer, and/or category of treatment request.

“The DWC IMR search tool allows the public to easily research the database of IMR decisions,” said DWC Acting Administrative Director George Parisotto. “Increased knowledge about the program’s past performance will ultimately lead to a more effective IMR process.”

Each IMR case pertains to one or more requested treatments that were denied, delayed or modified following utilization review (UR). The IMRO’s expert reviewers useevidence-based guidelines contained in the DWC Medical Treatment Utilization Schedule (MTUS) to determine whether to uphold or overturn the UR decision. The rationale for a reviewer’s decision for each requested treatment is provided in the IMR final determination letter.

Maximus Federal Services is the current Independent Medical Review Organization (IMRO) contracted by DWC to conduct IMR.

Maximus is based in Reston, Virginia, and is a publicly-traded for-profit corporation that receives government contracts to provide “business process services” to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company focuses primarily on “operating government-sponsored programs for vulnerable populations, such as Children’s Health Insurance Program (CHIP), Medicaid, health insurance exchanges and other health care reform initiatives under the Affordable Care Act, Medicare, welfare-to-work, and child support services,” according to its annual report.

And Maximus seems to be doing well. For the second quarter of fiscal 2016, Maximus revenue increased 26% to $606.5 million compared to $481.8 million reported for the same period last year. The increase in revenue was attributable to acquisitions that accounted for growth of 15% and organic growth of 13%, principally from the Health Services Segment. The increase in revenue was partially offset by a 2% decline from unfavorable foreign currency translation.

Health Services Segment revenue for the second quarter of fiscal 2016 increased 22% to $330.6 million compared to $270.9 million reported for the same period last year. The Company still expects revenue to range between $2.4 billion and $2.5 billion for fiscal 2016.

Proposed Law – Help For Children Born Dependent on Opioids

In an extremely rare unanimous vote, the U.S. House of Representatives on Wednesday passed legislation to improve safety planning for children who are born dependent on opioid drugs. A similar bill is pending in the Senate. It is one of more than a dozen new measures that are aimed at addressing a U.S. epidemic of addiction to pain pills and cheap heroin.

The legislation came in response to a Reuters investigation last year, titled “Helpless and Hooked,” which revealed that at least 110 babies had died since 2010 after being born dependent or exposed to opioids and sent home with parents ill-prepared to care for them.

“It’s hard to imagine that stories like these could be any more tragic,” Rep. Lou Barletta, a Pennsylvania Republican who is the prime sponsor of the bill, said on the House floor. “Unfortunately, they are. Because they should have and in many cases could have been prevented.” The Infant Plan of Safe Care Improvement Act (H.R. 4843), which Barletta authored with Rep. Katherine Clark (D-MA), requires that states which receive federal funds for child protective services comply with federal law and enact certain guidelines for the welfare of children exposed to opioids. The category of opioids includes a variety of pain medications or other drugs, such as heroin.

“Every 25 minutes in America, a baby is born suffering from opioid withdrawal. It’s an eye-opening statistic, and the more you consider what it really means, the more tragic it becomes,” Barletta said. “Every 25 minutes, a child enters the world having already been exposed to drugs. Every 25 minutes, a newborn has to pay the price for something he or she was defenseless against. Every 25 minutes, another infant becomes a victim of the national opioid crisis. These are the victims this bill will help protect.”

Only nine of the 50 U.S. states followed a federal law requiring them to track and help those newborns, Reuters reported. The news agency found that more than 130,000 newborns were diagnosed with drug withdrawal over the last decade, but most of them weren’t reported to state child-protection authorities.

In April, the U.S. Department of Health and Human Services asked all states to report by June 30 whether and how they are following the existing law, known as the Child Abuse Prevention and Treatment Act. States receive federal funding after giving assurance they are complying.

Children’s advocates are seeking more federal funding to go with the commitment. “We would view this as a good first step, but they need to make it real and put some money in it,” said John Sciamanna, vice president of public policy for the Child Welfare League of America.

Among the other opioid-related bills adopted by the House on Wednesday was one designed to help states emulate a pilot program for drug-affected newborns in Huntington, West Virginia. Rep. Evan Jenkins, a Republican who helped create the Huntington facility, known as Lily’s Place, before he became a congressman, said his bill would help improve access to care for poor babies and women on Medicare.

The Reuters series can be read here.

Fentanyl – The Deadly New Heroin

CNN reports that America’s addiction to opioid-based painkillers and heroin just got exponentially more dangerous. The most potent painkiller on the market, prescribed by doctors for cancer treatment, is being made illicitly and sold on the streets, delivering a super high and, far too often, death.

The drug, fentanyl, has been around since the 1960s. Its potency works miracles, soothing extreme pain in cancer patients who are usually prescribed patches or lozenges. But an illicit version of the drug is flooding into communities across America, and casual users are finding out that their fentanyl pills and powder are delivering a powerful high that is easy to overdose on. It can even kill. The Drug Enforcement Administration and the Centers for Disease Control say we have another national health crisis on our hands.

Fentanyl, a synthetic and short-acting opioid analgesic, is 50-100 times more potent than morphine. Although pharmaceutical fentanyl can be diverted for misuse, most cases of fentanyl-related morbidity and mortality have been linked to illicitly manufactured fentanyl and fentanyl analogs, collectively referred to as non-pharmaceutical fentanyl (NPF). NPF is sold via illicit drug markets for its heroin-like effect and often mixed with heroin and/or cocaine as a combination product – with or without the user’s knowledge – to increase its euphoric effects. While NPF-related overdoses can be reversed with naloxone, a higher dose or multiple number of doses per overdose event may be required to revive a patient due to the high potency of NPF. [

The latest state statistics on fentanyl-related deaths compiled by the CDC tell a sobering story. It first showed up in deadly doses on the streets in 2007. The DEA traced the illicit fentanyl to a single lab in Mexico and shut it down. Fentanyl drug seizures subsided for a while, but in 2014, they spiked in 10 states. It’s been an uphill battle. Americans are buying it in record numbers, and highly organized drug cartels are spreading it far and wide. What is curious is where the drug or elements to make it originate. Its street nickname is “China White” or “China girl,” offering a hint at where most of it is coming from.

Illicit fentanyl is a bestseller on the streets and a prolific killer. It is so potent that when law enforcement goes in to seize it, officers have to wear level A hazmat suits, the highest protection level made, the same kind of suits health care workers use to avoid contamination by the deadly Ebola virus. “Just micrograms can make a difference between life and death. It’s that serious,” said DEA Special Agent John Martin, who is based in San Francisco. An amount the size of a few grains of sand of fentanyl can kill you. “All you have to do is touch it. It can be absorbed through the skin and the eyes.”

And as far as profits go, the other opioids commonly sold on the streets — heroin, hydrocodone, OxyContin and Norco — can’t even touch fentanyl. Hydrocodone sells for about $30 a pill on the street. A fentanyl pill may look and cost the same but requires only a fraction of the narcotic to give users an even stronger reaction. The DEA estimates that drug traffickers can buy a kilogram of fentanyl powder for $3,300 and sell it on the streets for more than 300 times that, generating nearly a million dollars. Fentanyl is often trafficked through the cartels’ standard maze of routes through Mexico and into the U.S. But sometimes it’s simply ordered on the notorious dark web and shows up straight from China in the buyer’s mailbox.

“They look like what you’re getting from the pharmacy,” forensic scientist Terry Baisz said. She was taken aback by just how much the counterfeit pills look like the ones sold by pharmaceutical companies. After 26 years in the Orange County crime lab, south of Los Angeles, she has never seen anything like what is coming in these days. It worries her. “I was shocked the first time I tested this stuff and it came back as fentanyl. We hadn’t seen it before 2015,” Baisz said, “and now we’re seeing it a lot.” Fentanyl had entered Orange County, and it was killing people.

“It’s so dangerous and so lethal, I had to get involved,” California state Sen. Patricia Bates said. “Two minutes, and you could be in respiratory arrest and be dead. It’s kind of like, get high and die.” Bates knows those details because the fentanyl overdose deaths started racking up in one of the areas she represents, South Orange County. She is trying to push through a bill that would put harsher penalties on high-volume sellers of fentanyl. The bill “will enhance the penalties, by weight,” Bates said. “We’re talking about … catching the big guys, because when you take them out of the food chain, you really do reduce the incidents of the trafficking and what’s available on the streets.” She knows it’s a tough sell in a time when California voters have passed laws to lessen prison sentences for nonviolent offenders. And, of course, there is the matter of prison overcrowding in the state. But Bates is pushing it forward because she is certain this is the next epidemic, similar to what is happening with heroin but more deadly.

Dr. Raymond Meister New DWC Medical Direcor

The Department of Industrial Relations (DIR) and the Division of Workers’ Compensation (DWC) announced the appointment of Dr. Raymond Meister to the position of executive medical director for DWC.

“The medical unit is central to DWC’s mission to minimize the adverse impact of work-related injuries on California’s employees and employers,” said DWC Acting Administrative Director George Parisotto. “Under Dr. Meister’s leadership DWC will be able to provide quality care to injured workers and ensure the workers’ compensation system works for everyone.”

The executive medical director manages all medical and health-related programs in the DWC, and will provide policy guidance for the division and develop education and training for treating physicians. In addition, the medical director oversees provider networks and research plans related to medical care, and represents DWC on matters related to medical and health issues in workers’ compensation.

Dr. Meister has served as associate medical director for DWC since 2014. Prior to joining DWC, Dr. Meister served as public health medical officer at the California Department of Public Health from 2000 to 2014.

Dr. Meister earned a Master of Public Health degree from the University of California, Berkeley School of Public Health and a Doctor of Medicine degree from the University of Southern California School of Medicine. He has been an associate clinical professor at the University of California, San Francisco since 2009.

This position does not require Senate confirmation.

Martin Brady Reappointed to CHSWC

The Department of Industrial Relations (DIR) and the Commission on Health and Safety and Workers’ Compensation (CHSWC) announced the reappointment of Martin Brady to the commission, where he has served since 2012.

Governor Brown reappointed Brady as the public employer representative.

CHSWC Commissioners are appointed by the Governor and the Legislature. Labor Code 75 establishes that two of the employer members and two of the labor members of the Commission shall be appointed by the Governor for a total of four members.

Brady has been executive director at the Schools Insurance Authority since 1997, where he was a risk management and prevention manager from 1988 to 1997. He is a director of the California Association of Joint Powers Authority and the California Coalition on Workers Compensation. He earned a Master of Arts degree in physical education from California State University, Fresno.

CHSWC is a joint labor-management body created by the workers’ compensation reform legislation of 1993. CHSWC is charged with examining the health and safety and workers’ compensation systems in California and recommending administrative or legislative modifications to improve their operation. The Commission was established to conduct a continuing examination of the workers’ compensation system and of the state’s activities to prevent industrial injuries and occupational illnesses and to examine those programs in other states.

CHSWC also administers the Worker Occupational Safety and Health Training and Education Program (WOSHTEP), which sponsors workplace health and safety training programs and distributes educational materials on job safety.

This position does not require Senate confirmation.

Study Says “Inefficient” Prescribing Wastes Billions of Dollars

Nearly $73 billion was spent in the U.S. between 2010 and 2012 on brand name medications instead of less expensive alternatives, according to a new study. A large portion of that was spent by patients, the researchers found.

“Prescription drug prescribing during the time of this paper was not efficient and still isn’t efficient,” said lead author Dr. Michael Johansen, of Ohio State University in Columbus. “The number we’re spending on prescription drugs is really large. At least from what this paper shows, patients are bearing a disproportionate amount of the inefficiencies in our prescribing.”

One way to make prescribing more efficient is to order less expensive generic drugs to take the place of brand name medications. For example, instead of prescribing AstraZeneca’s Crestor, a statin drug for lowering high cholesterol, doctors might prescribe rosuvastatin, which is the less expensive generic form of Crestor.

Another, less widely accepted approach is known as therapeutic substitution. With therapeutic substitution, the patient would still receive a statin drug, but maybe not the same one he was taking before. He might receive atorvastatin, for example, which is the generic form of Pfizer’s Lipitor. Or he might receive simvastatin, the generic form of Merck’s Zocor. The patient would receive the least expensive drug in the same class of medications.

To see how much could possibly be saved with therapeutic substitution, Johansen and his co-author Dr. Caroline Richardson of the University of Michigan in Ann Arbor analyzed 2010-2012 data on 107,132 medication users.

As reported in JAMA Internal Medicine and summarized by Reuters Health, about 62 percent of participants reported using prescription drugs, and about a third were using a medication that was eligible for therapeutic substitution. Of the $760 billion spent on prescription drugs during the study period, about $73 billion may have been unnecessarily spent on brand name drugs, the researchers found. And nearly $25 billion of the $175 billion that patients paid out-of-pocket for their drugs during that time might have been saved by therapeutic substitutions.

The key to moving toward therapeutic substitution is to coordinate with doctors, said Johansen. It might be the case, he said, that a patient needs to take a specific generic drug for a specific reason.

His concerns are echoed in an editorial by Dr. Joseph Ross, JAMA Internal Medicine associate editor and associate professor at Yale University in New Haven, Connecticut. “To achieve the benefits of within-class substitution, we need wider adoption of systematic protocols, aligned with physician judgment, as to when such substitutions are beneficial and when not,” he wrote.

Johansen thinks it will take a lot of different interventions at different levels to overcome reluctance to implement therapeutic substitution, but policy efforts will probably be helpful. “Essentially the feeling you get with this is very similar to how people felt when generics were coming out,” he said. But, he pointed out, “The acceptance of generic drugs has improved.”

Two So Cal Doctors Convicted After Two Week Trial

After a two-week trial in Los Angeles, two doctors were found guilty of federal health care fraud charges for falsely certifying that Medicare patients were terminally ill, and therefore qualified for hospice care, when the vast majority of them were not actually dying. The doctors were found guilty of participating in a scheme related to the Covina-based California Hospice Care (CHC). CHC submitted approximately $8.8 million in fraudulent bills to Medicare and Medi-Cal for hospice-related services.

Sri Wijegoonaratna, known as Dr. J., 61, of Anaheim, who was found guilty of seven counts of health care fraud; and Boyao Huang, 43, of Pasadena, was found guilty of four counts of health care fraud. The two are scheduled to be sentenced on August 15, at which time each will face a statutory maximum sentence of 10 years in federal prison for each count of health care fraud.

“A number of patients admitted to California Hospice Care testified at trial, showing that they did not require end-of-life care,” said United States Attorney Eileen M. Decker. “In fact, only a small percentage of patients later died – notwithstanding the two doctors declaring that they needed hospice care. This scheme is one of many that has victimized public health care programs and, in the end, the taxpayers who fund these important programs. We will continue to investigate these fraudulent schemes, shut down the operations and incarcerate those responsible for stealing from the system.”

Four other defendants who were named in a federal grand jury indictment in September 2014 have pleaded guilty to health care fraud charges and are pending sentencing (except for one defendant who has been accepted into a diversion program). Those other defendants include a Placentia woman who purchased CHC in 2007 and operated the facility after being charged and incarcerated in another health care fraud scheme. Priscilla Villabroza, 70, previously pleaded guilty in December to one count of health care fraud and is scheduled to be sentenced on June 20.

As part of the CHC fraud scheme, Villabroza and her daughter – who was the nominal owner while Villabroza was in custody – paid patient recruiters known as “marketers” or “cappers” to bring in Medicare and Medi-Cal beneficiaries. CHC nurses performed “assessments” to determine whether the beneficiaries were terminally ill and, regardless of the outcome, Wijegoonaratna and Huang certified that the beneficiaries were terminally ill – even though the vast majority of them were not dying. CHC personnel altered medical records in response to Medicare audits to make the beneficiaries appear sicker.

The evidence at trial showed that Wijegoonaratna also recruited patients into the scheme and received tens of thousands of dollars in kickbacks. “Not only did defendant Wijegoonaratna refer beneficiaries to CHC in exchange for illegal kickbacks, but he also created fraudulent diagnoses and falsely certified that the referred beneficiaries were terminally ill, even though the overwhelming majority of CHC beneficiaries were not terminally ill, so that CHC could qualify for reimbursement from Medicare,” prosecutors wrote in court documents filed in relation to the trial. The California Medical Board has revoked Wijegoonaratna’s medical license.

The investigation into California Hospice was conducted by the United States Department of Health and Human Services, Office of Inspector General; the Federal Bureau of Investigation; the California Bureau of Medi-Cal Fraud & Elder Abuse; and IRS Criminal Investigation.

Todd Kelly Announces Retirement from His Firm

Todd Kelly, a Senior Partner, has announced his retirement from the firm of Floyd, Skeren & Kelly, LLP,.

Given his youth, he stated that he may undertake charitable projects in addition to his active involvement in the Boy Scouts, engage other business pursuits, look into other legal disciplines, or look into other avenues within workers’ compensation that involve neither litigation nor competition with FSK.

Mr. Kelly started with the Law Offices of John B. Floyd as an undergraduate college student and never looked back. During college and law school he was with us explained Mr. Floyd. When he passed the bar we were Floyd & Skeren and welcomed him in as a new attorney.

Mr. Kelly was made a partner in 1998 and the firm took on the Floyd, Skeren & Kelly name in 1998. Todd, as he is known to his friends and associates was an integral part of the firm’s growth over the last decade. He is known at the firm as not only a hard-nosed litigator but a knowledgeable marketer as he knows well the clients’ needs to defend their interests and to do so in a straight forward and economic fashion.

Although he is leaving the firm, Senior Partner’s Amanda Manukian and John Langevin aptly described that he will be gone but only a phone call away when his wisdom is needed.

The whole firm, but particularly the partners, will miss his presence, sense of humor and friendship.

DJ Faces Jail Time for Forged Certificate of Insurance

Carlos Rojas, 33, of Huntington Beach, surrendered to the Los Angeles Police Department on a warrant obtained by California Department of Insurance detectives and is facing a felony charge of forgery.

Rojas, doing business as ALIST Entertainment, allegedly submitted a fraudulent certificate of liability insurance to the nightclub, Avalon Hollywood, where he hosted an event titled College Club Night. During the event, a fight ensued that led to the performing disc jockey being injured. The injured disc jockey attempted to file a workers’ compensation claim against the Avalon Hollywood nightclub.

Investigations by both the insurance company and the California Department of Insurance revealed neither Rojas nor ALIST Entertainment was a client and revealed that Rojas allegedly provided the nightclub with a forged certificate of liability insurance.

Once it was determined the promoter did not have the required liability insurance, the injured DJ attempted to file a claim against the nightclub, which left the club liable for all workers’ compensation, legal and administrative fees associated with the claim.

The DJ has the option of pursuing his claim through the California Uninsured Employers Benefits Trust Fund, which was established to provide payment to injured employees of illegally uninsured employers like Rojas.

Bail was set at $40,000. Rojas was released on his own recognizance. This case is being prosecuted by the Los Angeles County District Attorney’s Office